Hsbc Holdings PLC Teva Pharmaceutical Industries LTD Call Options Transaction History

Hsbc Holdings PLC

11 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2021 Nov 12, 2021	SELL	$8.38 - $10.18 $25,140 - $30,540	-3,000 Reduced 5.65%	50,100 $488,000
Q2 2021 Aug 13, 2021	SELL	$9.9 - $11.56 $267,300 - $312,120	-27,000 Reduced 33.71%	53,100 $525,000
Q1 2021 May 14, 2021	SELL	$10.34 - $12.81 $522,170 - $646,905	-50,500 Reduced 38.67%	80,100 $924,000
Q4 2020 Feb 25, 2021	BUY	$8.61 - $11.04 $495,074 - $634,800	57,500 Added 78.66%	130,600 $1.26 Million
Q4 2020 Feb 12, 2021	BUY	$8.61 - $11.04 $189,420 - $242,879	22,000 Added 43.05%	73,100 $705,000
Q3 2020 Nov 12, 2020	BUY	$8.57 - $12.69 $189,397 - $280,449	22,100 Added 76.21%	51,100 $460,000
Q3 2018 Nov 13, 2018	SELL	$21.06 - $25.65 $1.84 Million - $2.24 Million	-87,400 Reduced 75.09%	29,000 $625,000
Q2 2018 Aug 10, 2018	BUY	$16.77 - $24.71 $1.63 Million - $2.41 Million	97,400 Added 512.63%	116,400 $2.83 Million
Q1 2018 May 11, 2018	BUY	$16.68 - $22.07 $250,200 - $331,050	15,000 Added 375.0%	19,000 $324,000
Q4 2017 Feb 14, 2018	BUY	$11.23 - $19.1 $22,460 - $38,200	2,000 Added 100.0%	4,000 $76,000
Q2 2017 Aug 14, 2017	BUY	N/A	2,000	2,000 $66,000

625

573M

19.6M

6.77M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $25.1B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Hsbc Holdings PLC with notifications on news.